This indicated that H2BC12 might predict the survival outcome of gliomas, which was consistent with a previous study that showed that signatures based on histone gene family are potentially good indicators for the outcome of cervical cancer patients (Li et al., 2017). This evidence concerns the gene H2BC12 and cervical cancer.